Supply of FDA-Approved F-18 Fludeoxyglucose (FDG) Radiopharmaceuticals

The contract requires the supply of FDA-approved F-18 fludeoxyglucose (FDG) radiopharmaceuticals in unit-dose form for nuclear medicine imaging at DDEAMC, specifically to support calibration and operational schedules at Fort Gordon, Georgia. All delivered products must comply strictly with FDA regulations and quality standards to ensure patient safety and diagnostic accuracy. Timely delivery is critical, as the radiopharmaceuticals are subject to rapid radioactive decay and must align precisely with imaging protocols and scheduled patient appointments. The subcontract is issued under NAICS code 325412, indicating classification within the pharmaceutical manufacturing sector, and is managed by the Department of Defense through the W40M MRC0 West office. Responses are due by May 7, 2026, at 6:00 p.m., with the opportunity posted on April 30, 2026. Performance is required solely at Fort Gordon, and there is no set-aside designation specified. The provider must ensure consistent, reliable production and logistics to maintain uninterrupted service for military medical imaging needs, with no tolerance for delays or non-compliance.